Article

Evaluating Drug Response in 3D Triple Negative Breast Cancer Tumoroids with High Content Imaging and Analysis

2022-08-03

Abstract excerpt

There is a critical need to develop methods for efficient testing of drug efficacy in patient-derived tumor samples to discover new therapeutics. Two-dimensional (2D) cell culture remains the primary method of drug screening, despite being considered less physiologically relevant than three-dimensional (3D) culture. Increased complexity and technical challenges of 3D systems have limited its widespread adoption as...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d5388a0d-f1e0-5d89-b204-cbf3642e7026
DOI: 10.21203/rs.3.rs-1859525/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluating Drug Response in 3D Triple Negative Breast Cancer Tumoroids with High Content Imaging and AnalysisDOI 10.21203/rs.3.rs-1859525/v1Read

Label-free morphometric profiling reveals early drug responses in 3D tumor spheroidsSemantic proximity Read

Ultra high content image analysis and phenotype profiling of 3D cultured micro-tissues.Semantic proximity Read

Multidimensional Profiling of Drug-Treated Cells by Imaging Mass CytometrySemantic proximity Read

Towards optimized breast cancer 3D spheroid mono- and co-culture models for pharmacological research and screeningSemantic proximity Read

Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug ScreeningSemantic proximity Read

In vitro breast cancer model with patient-specific morphological features for personalized medicineSemantic proximity Read

Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapySemantic proximity Read

Multiplexed live-cell imaging for drug responses in patient-derived organoid models of cancerSemantic proximity Read

High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.Semantic proximity Read

Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform.Semantic proximity Read

Development of a 3D Tissue Culture–Based High-Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine KinasesSemantic proximity Read

Microscopy-based phenotypic monitoring of MDA-MB-231 spheroids allows the evaluation of phenotype-directed therapy.Semantic proximity Read